Biochemical and Biophysical Research Communications · 2012 · 28 citations · 27 references
MedicineOncologyPharmacologyCancer PharmacologyChemotherapyMolecular OncologyCancer ImmunotherapyChemotherapy In Hematologic MalignanciesHematologic Malignancy PharmacotherapyHematologic Malignancy TherapyMultiple MyelomaTyrosine Kinase InhibitorsBortezomib TherapyBortezomib-based TherapyDifferentiation InductionMultiple Myeloma ChemotherapyMultiple Myeloma TherapyMultiple Myeloma TreatmentRefractory Multiple Myeloma
27
Ahmedin Jemal, Rebecca L. Siegel, Elizabeth Ward et al. · CA A Cancer Journal for Clinicians · 2007 · 7.5K citations · Full text
Bortezomib or High-Dose Dexamethasone for Relapsed Multiple Myeloma
Paul G. Richardson, Pieter Sonneveld, Michael W. Schuster et al. · New England Journal of Medicine · 2005 · 2.5K citations · Full text
Rapid degradation of a large fraction of newly synthesized proteins by proteasomes
Ulrich S. Schubert, Luis C. Antón, James S. Gibbs et al. · Nature · 2000 · 1.5K citations
Plasma cell differentiation requires the transcription factor XBP-1
Andreas Reimold, Neal N. Iwakoshi, John Manis et al. · Nature · 2001 · 1.3K citations